Evidence map›Paper›PMID 31089162›Full record

ArticleScientific reports2019

Simple Surface Modification of Poly(dimethylsiloxane) via Surface Segregating Smart Polymers for Biomicrofluidics.

Aslıhan Gökaltun, Young Bok Abraham Kang, Martin L Yarmush, O Berk Usta, Ayse Asatekin

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 246 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Fast, StreamlinedChemical & biomedical imaging · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Phase-Dependent MoSInternational journal of molecular sciences · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Aslıhan GökaltunCenter for Engineering in Medicine at Massachusetts General Hospital, Harvard Medical School, and Shriners Hospital for Children, 51 Blossom St., Boston, MA, 02114, USA.
Young Bok Abraham KangCenter for Engineering in Medicine at Massachusetts General Hospital, Harvard Medical School, and Shriners Hospital for Children, 51 Blossom St., Boston, MA, 02114, USA.ORCID http://orcid.org/0000-0002-8562-3797
Martin L YarmushCenter for Engineering in Medicine at Massachusetts General Hospital, Harvard Medical School, and Shriners Hospital for Children, 51 Blossom St., Boston, MA, 02114, USA.
O Berk UstaCenter for Engineering in Medicine at Massachusetts General Hospital, Harvard Medical School, and Shriners Hospital for Children, 51 Blossom St., Boston, MA, 02114, USA. berkusta@gmail.com.ORCID http://orcid.org/0000-0001-9328-568X
Ayse AsatekinDepartment of Chemical and Biological Engineering, Tufts University, 4 Colby Street, Medford, MA, 02474, USA. ayse.asatekin@tufts.edu.
Shriners Hospitals for Children - Erie · USTufts University · USRutgers, The State University of New Jersey · US

Funding

Bio-MicroElectroMechanical Systems Resource CenterP41EB002503 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET · 2004 to 2018
$17.4M
Novel Microfluidic Platforms for Actively Controlled in-vitro Liver ZonationR21EB020192 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI USTA, OSMAN BERK · 2015 to 2016
$479k
NIBIB NIH HHS P41 EB002503NIBIB NIH HHS R21 EB020192
6 · The paper itself

Abstract

Poly(dimethylsiloxane) (PDMS) is likely the most popular material for microfluidic devices in lab-on-a-chip and other biomedical applications. However, the hydrophobicity of PDMS leads to non-specific adsorption of proteins and other molecules such as therapeutic drugs, limiting its broader use. Here, we introduce a simple method for preparing PDMS materials to improve hydrophilicity and decrease non-specific protein adsorption while retaining cellular biocompatibility, transparency, and good mechanical properties without the need for any post-cure surface treatment. This approach utilizes smart copolymers comprised of poly(ethylene glycol) (PEG) and PDMS segments (PDMS-PEG) that, when blended with PDMS during device manufacture, spontaneously segregate to surfaces in contact with aqueous solutions and reduce the hydrophobicity without any added manufacturing steps. PDMS-PEG-modified PDMS samples showed contact angles as low as 23.6° ± 1° and retained this hydrophilicity for at least twenty months. Their improved wettability was confirmed using capillary flow experiments. Modified devices exhibited considerably reduced non-specific adsorption of albumin, lysozyme, and immunoglobulin G. The modified PDMS was biocompatible, displaying no adverse effects when used in a simple liver-on-a-chip model using primary rat hepatocytes. This PDMS modification method can be further applied in analytical separations, biosensing, cell studies, and drug-related studies.

Indexed as

Lab-On-A-Chip DevicesAnimalsCells, CulturedDimethylpolysiloxanesHepatocytesHydrophobic and Hydrophilic InteractionsMaterials TestingMicrofluidic Analytical TechniquesPolyethylene GlycolsPrimary Cell CultureRatsStimuli Responsive PolymersSurface PropertiesbaysilonDimethylpolysiloxanesPolyethylene GlycolsStimuli Responsive Polymers

Identifiers

PMID31089162
PMCPMC6517421
OpenAlexW2946593644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.